BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 15459709)

  • 1. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs.
    Forman MS; Trojanowski JQ; Lee VM
    Nat Med; 2004 Oct; 10(10):1055-63. PubMed ID: 15459709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Conformationally altered proteins cause neurodegenerative diseases].
    Ingelsson M; Nilsson L; Basun H; Aquilonius SM; Lannfelt L
    Lakartidningen; 2005 Nov 21-27; 102(47):3542-3, 3545-6, 3549 passim. PubMed ID: 16408392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein misfolding in neurodegenerative diseases.
    Agorogiannis EI; Agorogiannis GI; Papadimitriou A; Hadjigeorgiou GM
    Neuropathol Appl Neurobiol; 2004 Jun; 30(3):215-24. PubMed ID: 15175075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The alternative role of 14-3-3 zeta as a sweeper of misfolded proteins in disease conditions.
    Kaneko K; Hachiya NS
    Med Hypotheses; 2006; 67(1):169-71. PubMed ID: 16516399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic animal models of neurodegenerative diseases and their application to treatment development.
    Rockenstein E; Crews L; Masliah E
    Adv Drug Deliv Rev; 2007 Sep; 59(11):1093-102. PubMed ID: 17869376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanical stress and formation of protein aggregates in neurodegenerative disorders.
    Hachiya NS; Kozuka Y; Kaneko K
    Med Hypotheses; 2008; 70(5):1034-7. PubMed ID: 17910993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward a molecular neuropsychiatry of neurodegenerative diseases.
    Cummings JL
    Ann Neurol; 2003 Aug; 54(2):147-54. PubMed ID: 12891666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
    Yoshida K; Higuchi K; Ikeda S
    Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of neurodegenerative diseases: insights from live cell imaging.
    Weissmann C; Brandt R
    J Neurosci Res; 2008 Feb; 86(3):504-11. PubMed ID: 17668854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diseases associated with protein aggregation].
    Bak D; Milewski M
    Postepy Biochem; 2005; 51(3):297-307. PubMed ID: 16381174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid oligomers: dynamics and toxicity in the cytosol and nucleus.
    Kitamura A; Kubota H
    FEBS J; 2010 Mar; 277(6):1369-79. PubMed ID: 20148962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers of neurodegenerative disorders: how good are they?
    Rachakonda V; Pan TH; LE WD
    Cell Res; 2004 Oct; 14(5):347-58. PubMed ID: 15538967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications.
    Williams A; Jahreiss L; Sarkar S; Saiki S; Menzies FM; Ravikumar B; Rubinsztein DC
    Curr Top Dev Biol; 2006; 76():89-101. PubMed ID: 17118264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's disease, proteins, and prions: milestones.
    Olanow CW; McNaught K
    Mov Disord; 2011 May; 26(6):1056-71. PubMed ID: 21626551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein aggregation in the pathogenesis of familial and sporadic Parkinson's disease.
    McNaught KS; Olanow CW
    Neurobiol Aging; 2006 Apr; 27(4):530-45. PubMed ID: 16207501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy and naturally occurring autoantibodies in neurodegenerative disorders.
    Neff F; Wei X; Nölker C; Bacher M; Du Y; Dodel R
    Autoimmun Rev; 2008 Jun; 7(6):501-7. PubMed ID: 18558370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lewy bodies in the amygdala: increase of alpha-synuclein aggregates in neurodegenerative diseases with tau-based inclusions.
    Popescu A; Lippa CF; Lee VM; Trojanowski JQ
    Arch Neurol; 2004 Dec; 61(12):1915-9. PubMed ID: 15596612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of polyunsaturated fatty acids for misfolding protein aggregations: implication for neurodegenerative diseases.
    Kim YJ; Takahashi R
    Ann N Y Acad Sci; 2006 Nov; 1086():11-20. PubMed ID: 17185502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxic proteins in neurodegenerative disease.
    Taylor JP; Hardy J; Fischbeck KH
    Science; 2002 Jun; 296(5575):1991-5. PubMed ID: 12065827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases.
    Pawar AP; Dubay KF; Zurdo J; Chiti F; Vendruscolo M; Dobson CM
    J Mol Biol; 2005 Jul; 350(2):379-92. PubMed ID: 15925383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.